CareDx Reports Director/Officer Changes & Financials
Ticker: CDNA · Form: 8-K · Filed: Oct 4, 2024 · CIK: 1217234
Sentiment: neutral
Topics: corporate-governance, officer-changes, financial-reporting
Related Tickers: CDNA
TL;DR
CareDx filed an 8-K detailing director/officer changes and financial updates as of Sept 30.
AI Summary
CareDx, Inc. filed an 8-K on October 4, 2024, reporting on the departure of directors, election of new directors, appointment of officers, and compensatory arrangements. The filing also includes financial statements and exhibits as of September 30, 2024. Specific details regarding the individuals involved in the director and officer changes, as well as the terms of any new compensatory arrangements, are expected to be elaborated within the filing's exhibits.
Why It Matters
Changes in a company's board of directors and executive officers can signal shifts in strategy or governance, while the inclusion of financial statements provides insight into the company's current financial health.
Risk Assessment
Risk Level: medium — Changes in directorship and officers, coupled with financial reporting, can indicate internal shifts that may impact future performance.
Key Players & Entities
- CareDx, Inc. (company) — Registrant
- September 30, 2024 (date) — Date of earliest event reported
- October 4, 2024 (date) — Date of report
- Delaware (jurisdiction) — State of Incorporation
FAQ
What specific changes occurred regarding directors and officers of CareDx, Inc. as of September 30, 2024?
The filing indicates the departure of directors, election of new directors, and appointment of certain officers, with details expected in the exhibits.
What is the significance of the 'Compensatory Arrangements of Certain Officers' item in this 8-K filing?
This item suggests that the filing includes information regarding the compensation packages or agreements for specific executive officers of CareDx, Inc.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this filing was on September 30, 2024.
What is the principal executive office address for CareDx, Inc. as stated in the filing?
The principal executive offices are located at 8000 Marina Boulevard, 4th Floor, Brisbane, California 94005.
What other items are covered by this 8-K filing besides director and officer changes?
In addition to changes in directors or certain officers and compensatory arrangements, the filing also covers Financial Statements and Exhibits.
Filing Stats: 1,136 words · 5 min read · ~4 pages · Grade level 11.3 · Accepted 2024-10-04 16:05:17
Key Financial Figures
- $0.001 — nge on which registered) Common Stock, $0.001 Par Value CDNA The Nasdaq Stock Market
- $517,920 — , (ii) a lump sum cash payment equal to $517,920, representing 200% of his target bonus
- $300,000 — (iii) a lump sum cash payment equal to $300,000, representing the unpaid portion of the
- $107,901 — ill pay Mr. Johnson an aggregate fee of $107,901 (the "Fee"), payable in a lump sum at t
Filing Documents
- cdna-20240930.htm (8-K) — 36KB
- exhibit101-separationagree.htm (EX-10.1) — 58KB
- exhibit102-consultingagree.htm (EX-10.2) — 79KB
- imagea.jpg (GRAPHIC) — 23KB
- 0001217234-24-000089.txt ( ) — 354KB
- cdna-20240930.xsd (EX-101.SCH) — 2KB
- cdna-20240930_lab.xml (EX-101.LAB) — 21KB
- cdna-20240930_pre.xml (EX-101.PRE) — 12KB
- cdna-20240930_htm.xml (XML) — 3KB
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 10.1 Separation Agreement and Release of Claims, dated September 30, 2024, between CareDx, Inc. and Alexander Johnson. 10.2 Consulting Agreement, dated September 30, 2024, between CareDx, Inc. and Alexander Johnson. 104 Cover Page Interactive Data File, formatted in Inline Extensible Business Reporting Language (iXBRL).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 4, 2024 CAREDX, INC. By: /s/ John W. Hanna John W. Hanna President and Chief Executive Officer